126 related articles for article (PubMed ID: 38030024)
1. Monochasma savatieri Franch. protects against acute lung injury via α7nAChR-TLR4/NF-κB p65 signaling pathway based on integrated pharmacology analysis.
Zhao M; Yang M; Du J; Cao X; Zhong L; Li W; Chen Y; Peng M; Guo H; Zhou T; Zhang C; Ren Z; Ding Z; Zhong R; Wang Y; Shu Z
J Ethnopharmacol; 2024 Mar; 321():117487. PubMed ID: 38030024
[TBL] [Abstract][Full Text] [Related]
2. Shiwei Qingwen decoction regulates TLR4/NF-κB signaling pathway and NLRP3 inflammasome to reduce inflammatory response in lipopolysaccharide-induced acute lung injury.
Zhang Q; Yang C; Ma S; Guo S; Hu X; Zhou Z; Liu Y; Zhang X; Jiang R; Zhang Z; Wen L
J Ethnopharmacol; 2023 Sep; 313():116615. PubMed ID: 37164255
[TBL] [Abstract][Full Text] [Related]
3. The protective effects of Mai-Luo-Ning injection against LPS-induced acute lung injury via the TLR4/NF-κB signalling pathway.
Miao J; Shen J; Yan C; Ren J; Liu H; Qiao Y; Li Q
Phytomedicine; 2022 Sep; 104():154290. PubMed ID: 35793597
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-27a alleviates LPS-induced acute lung injury in mice via inhibiting inflammation and apoptosis through modulating TLR4/MyD88/NF-κB pathway.
Ju M; Liu B; He H; Gu Z; Liu Y; Su Y; Zhu D; Cang J; Luo Z
Cell Cycle; 2018; 17(16):2001-2018. PubMed ID: 30231673
[TBL] [Abstract][Full Text] [Related]
5. Huoxiang Zhengqi Oral Liquid Attenuates LPS-Induced Acute Lung Injury by Modulating Short-Chain Fatty Acid Levels and TLR4/NF-
Tang R; Zhang J; Zhang R; Li X; Lv R; Nan H; Liu J; Zhao Z; He W; Wang L
Biomed Res Int; 2023; 2023():6183551. PubMed ID: 36845637
[TBL] [Abstract][Full Text] [Related]
6. Guben Qingfei decoction attenuates LPS-induced acute lung injury by modulating the TLR4/NF-κB and Keap1/Nrf2 signaling pathways.
Zeng Z; Fu Y; Li M; Shi Y; Ding Q; Chen S
J Ethnopharmacol; 2024 Apr; 323():117674. PubMed ID: 38154525
[TBL] [Abstract][Full Text] [Related]
7. An integrated RNA-Seq and network pharmacology approach for exploring the preventive effect of Corydalis bungeana Turcz. Extract and Acetylcorynoline on LPS-induced acute lung injury.
Li Q; Xiang Y; Zhang Z; Qu X; Wu J; Fu J; Zhu F; Tang H
J Ethnopharmacol; 2024 Jan; 318(Pt B):117048. PubMed ID: 37586441
[TBL] [Abstract][Full Text] [Related]
8. Ulinastatin Protects Against LPS-Induced Acute Lung Injury By Attenuating TLR4/NF-κB Pathway Activation and Reducing Inflammatory Mediators.
Cao C; Yin C; Shou S; Wang J; Yu L; Li X; Chai Y
Shock; 2018 Nov; 50(5):595-605. PubMed ID: 29324628
[TBL] [Abstract][Full Text] [Related]
9. Xuanfei Baidu Formula attenuates LPS-induced acute lung injury by inhibiting the NF-κB signaling pathway.
Zhu Y; Luo L; Zhang M; Song X; Wang P; Zhang H; Zhang J; Liu D
J Ethnopharmacol; 2023 Jan; 301():115833. PubMed ID: 36252879
[TBL] [Abstract][Full Text] [Related]
10. Kegan Liyan oral liquid ameliorates lipopolysaccharide-induced acute lung injury through inhibition of TLR4-mediated NF-κB signaling pathway and MMP-9 expression.
Zhang X; Sun CY; Zhang YB; Guo HZ; Feng XX; Peng SZ; Yuan J; Zheng RB; Chen WP; Su ZR; Huang XD
J Ethnopharmacol; 2016 Jun; 186():91-102. PubMed ID: 27036629
[TBL] [Abstract][Full Text] [Related]
11. Apigenin C-glycosides of Microcos paniculata protects lipopolysaccharide induced apoptosis and inflammation in acute lung injury through TLR4 signaling pathway.
Li K; He Z; Wang X; Pineda M; Chen R; Liu H; Ma K; Shen H; Wu C; Huang N; Pan T; Liu Y; Guo J
Free Radic Biol Med; 2018 Aug; 124():163-175. PubMed ID: 29890216
[TBL] [Abstract][Full Text] [Related]
12. Jinhua Qinggan granules attenuates acute lung injury by promotion of neutrophil apoptosis and inhibition of TLR4/MyD88/NF-κB pathway.
Zhu Y; Han Q; Wang L; Wang B; Chen J; Cai B; Wu C; Zhu X; Liu F; Han D; Dong H; Jia Y; Liu Y
J Ethnopharmacol; 2023 Jan; 301():115763. PubMed ID: 36183949
[TBL] [Abstract][Full Text] [Related]
13. Systems pharmacology reveals the mechanism of activity of Ge-Gen-Qin-Lian decoction against LPS-induced acute lung injury: A novel strategy for exploring active components and effective mechanism of TCM formulae.
Ding Z; Zhong R; Yang Y; Xia T; Wang W; Wang Y; Xing N; Luo Y; Li S; Shang L; Shu Z
Pharmacol Res; 2020 Jun; 156():104759. PubMed ID: 32200026
[TBL] [Abstract][Full Text] [Related]
14. Physalin B ameliorates inflammatory responses in lipopolysaccharide-induced acute lung injury mice by inhibiting NF-κB and NLRP3 via the activation of the PI3K/Akt pathway.
Zhong R; Xia T; Wang Y; Ding Z; Li W; Chen Y; Peng M; Li C; Zhang H; Shu Z
J Ethnopharmacol; 2022 Feb; 284():114777. PubMed ID: 34737012
[TBL] [Abstract][Full Text] [Related]
15. Protective effect of forsythoside B against lipopolysaccharide-induced acute lung injury by attenuating the TLR4/NF-κB pathway.
Liu JX; Li X; Yan FG; Pan QJ; Yang C; Wu MY; Li G; Liu HF
Int Immunopharmacol; 2019 Jan; 66():336-346. PubMed ID: 30521962
[TBL] [Abstract][Full Text] [Related]
16. Protective Effects of
Shi K; Xiao Y; Dong Y; Wang D; Xie Y; Tu J; Xu K; Zhou Z; Cao G; Liu Y
Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555773
[TBL] [Abstract][Full Text] [Related]
17. Jinzhen Oral Liquid alleviates lipopolysaccharide-induced acute lung injury through modulating TLR4/MyD88/NF-κB pathway.
Li YL; Qin SY; Li Q; Song SJ; Xiao W; Yao GD
Phytomedicine; 2023 Jun; 114():154744. PubMed ID: 36934667
[TBL] [Abstract][Full Text] [Related]
18. Ferulic acid alleviates lipopolysaccharide-induced acute lung injury through inhibiting TLR4/NF-κB signaling pathway.
Wu X; Lin L; Wu H
J Biochem Mol Toxicol; 2021 Mar; 35(3):e22664. PubMed ID: 33140555
[TBL] [Abstract][Full Text] [Related]
19. rFGF4 alleviates lipopolysaccharide-induced acute lung injury by inhibiting the TLR4/NF-κB signaling pathway.
Wang X; Zhou L; Ye S; Liu S; Chen L; Cheng Z; Huang Y; Wang B; Pan M; Wang D; Wang L; Lei Z; Im YJ; Li X
Int Immunopharmacol; 2023 Apr; 117():109923. PubMed ID: 36842235
[TBL] [Abstract][Full Text] [Related]
20. Shufeng Jiedu capsule inhibits inflammation and apoptosis by activating A2AAR and inhibiting NF-κB to alleviate LPS-induced ALI.
Cai J; Wang YL; Sheng XD; Zhang L; Lv X
J Ethnopharmacol; 2022 Nov; 298():115661. PubMed ID: 36002086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
